Selected research
Industry Growth & Trends
Global Animal Blood Plasma Products and Derivatives Industry Growth and Trends Forecast to 2032
Market perspective
The global Animal Blood Plasma Products and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Animal Blood Plasma Products and Derivatives include Thermo Fisher Scientific, Sigma-Aldrich, Rocky Mountain Biologicals, Proliant, LAMPIRE Biological Laboratories, Lake Immunogenics, Kraeber & Co. GmbH, Bovogen Biologicals and Auckland BioSciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Animal Blood Plasma Products and Derivatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Animal Blood Plasma Products and Derivatives market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal Blood Plasma Products and Derivatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal Blood Plasma Products and Derivatives.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Animal Blood Plasma Products and Derivatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Animal Blood Plasma Products and Derivatives Market by Company
Thermo Fisher Scientific
Sigma-Aldrich
Rocky Mountain Biologicals
Proliant
LAMPIRE Biological Laboratories
Lake Immunogenics
Kraeber & Co. GmbH
Bovogen Biologicals
Auckland BioSciences
ANZCO Foods
Animal Blood Plasma Products and Derivatives Segment by Type
Serum Albumin
Fibrinogen
Fetal Bovine Serum
Immunoglobulin
Animal Blood Plasma Products and Derivatives Segment by Application
Pharmaceutical Industry
Diagnostic Industry
Sports Nutrition
Nutrition Supplements
Cell Culture Media
Food Industry
Cosmetic Industry
Pet Food Industry
Animal Blood Plasma Products and Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Blood Plasma Products and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Blood Plasma Products and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Blood Plasma Products and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Blood Plasma Products and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Animal Blood Plasma Products and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Albumin
- Fibrinogen
- Fetal Bovine Serum
- Immunoglobulin
Applications
- Pharmaceutical Industry
- Diagnostic Industry
- Sports Nutrition
- Nutrition Supplements
- Cell Culture Media
- Food Industry
- Cosmetic Industry
- Pet Food Industry
Companies covered
- Thermo Fisher Scientific
- Sigma-Aldrich
- Rocky Mountain Biologicals
- Proliant
- LAMPIRE Biological Laboratories
- Lake Immunogenics
- Kraeber & Co. GmbH
- Bovogen Biologicals
- Auckland BioSciences
- ANZCO Foods
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Animal Blood Plasma Products and Derivatives Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Animal Blood Plasma Products and Derivatives Sales Estimates and Forecasts (2021-2032)
- 1.3 Animal Blood Plasma Products and Derivatives Market by Type
- 1.3.1 Serum Albumin
- 1.3.2 Fibrinogen
- 1.3.3 Fetal Bovine Serum
- 1.3.4 Immunoglobulin
- 1.4 Global Animal Blood Plasma Products and Derivatives Market Size by Type
- 1.4.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Type (2021-2032)
- 1.4.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Animal Blood Plasma Products and Derivatives Industry Trends
- 2.2 Animal Blood Plasma Products and Derivatives Industry Drivers
- 2.3 Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges
- 2.4 Animal Blood Plasma Products and Derivatives Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Animal Blood Plasma Products and Derivatives Revenue (2021-2026)
- 3.2 Global Top Players by Animal Blood Plasma Products and Derivatives Sales (2021-2026)
- 3.3 Global Top Players by Animal Blood Plasma Products and Derivatives Price (2021-2026)
- 3.4 Global Animal Blood Plasma Products and Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Animal Blood Plasma Products and Derivatives Major Company Production Sites & Headquarters
- 3.6 Global Animal Blood Plasma Products and Derivatives Company, Product Type & Application
- 3.7 Global Animal Blood Plasma Products and Derivatives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Animal Blood Plasma Products and Derivatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Animal Blood Plasma Products and Derivatives Players Market Share by Revenue in 2025
- 3.8.3 2025 Animal Blood Plasma Products and Derivatives Tier 1, Tier 2, and Tier 3
4 Animal Blood Plasma Products and Derivatives Regional Status and Outlook
- 4.1 Global Animal Blood Plasma Products and Derivatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size by Region
- 4.2.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2021-2026)
- 4.2.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2021-2026)
- 4.2.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Region
- 4.3.1 Global Animal Blood Plasma Products and Derivatives Sales in Volume by Region (2027-2032)
- 4.3.2 Global Animal Blood Plasma Products and Derivatives Sales in Value by Region (2027-2032)
- 4.3.3 Global Animal Blood Plasma Products and Derivatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal Blood Plasma Products and Derivatives by Application
- 5.1 Animal Blood Plasma Products and Derivatives Market by Application
- 5.1.1 Pharmaceutical Industry
- 5.1.2 Diagnostic Industry
- 5.1.3 Sports Nutrition
- 5.1.4 Nutrition Supplements
- 5.1.5 Cell Culture Media
- 5.1.6 Food Industry
- 5.1.7 Cosmetic Industry
- 5.1.8 Pet Food Industry
- 5.2 Global Animal Blood Plasma Products and Derivatives Market Size by Application
- 5.2.1 Global Animal Blood Plasma Products and Derivatives Market Size Overview by Application (2021-2032)
- 5.2.2 Global Animal Blood Plasma Products and Derivatives Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Animal Blood Plasma Products and Derivatives Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Sigma-Aldrich
- 6.2.1 Sigma-Aldrich Company Information
- 6.2.2 Sigma-Aldrich Business Overview
- 6.2.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.2.5 Sigma-Aldrich Recent Developments
- 6.3 Rocky Mountain Biologicals
- 6.3.1 Rocky Mountain Biologicals Company Information
- 6.3.2 Rocky Mountain Biologicals Business Overview
- 6.3.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.3.5 Rocky Mountain Biologicals Recent Developments
- 6.4 Proliant
- 6.4.1 Proliant Company Information
- 6.4.2 Proliant Business Overview
- 6.4.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.4.5 Proliant Recent Developments
- 6.5 LAMPIRE Biological Laboratories
- 6.5.1 LAMPIRE Biological Laboratories Company Information
- 6.5.2 LAMPIRE Biological Laboratories Business Overview
- 6.5.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.5.5 LAMPIRE Biological Laboratories Recent Developments
- 6.6 Lake Immunogenics
- 6.6.1 Lake Immunogenics Company Information
- 6.6.2 Lake Immunogenics Business Overview
- 6.6.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.6.5 Lake Immunogenics Recent Developments
- 6.7 Kraeber & Co. GmbH
- 6.7.1 Kraeber & Co. GmbH Company Information
- 6.7.2 Kraeber & Co. GmbH Business Overview
- 6.7.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.7.5 Kraeber & Co. GmbH Recent Developments
- 6.8 Bovogen Biologicals
- 6.8.1 Bovogen Biologicals Company Information
- 6.8.2 Bovogen Biologicals Business Overview
- 6.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.8.5 Bovogen Biologicals Recent Developments
- 6.9 Auckland BioSciences
- 6.9.1 Auckland BioSciences Company Information
- 6.9.2 Auckland BioSciences Business Overview
- 6.9.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.9.5 Auckland BioSciences Recent Developments
- 6.10 ANZCO Foods
- 6.10.1 ANZCO Foods Company Information
- 6.10.2 ANZCO Foods Business Overview
- 6.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
- 6.10.5 ANZCO Foods Recent Developments
7 North America by Country
- 7.1 North America Animal Blood Plasma Products and Derivatives Sales by Country
- 7.1.1 North America Animal Blood Plasma Products and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
- 7.1.3 North America Animal Blood Plasma Products and Derivatives Sales Forecast by Country (2027-2032)
- 7.2 North America Animal Blood Plasma Products and Derivatives Market Size by Country
- 7.2.1 North America Animal Blood Plasma Products and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Animal Blood Plasma Products and Derivatives Market Size by Country (2021-2026)
- 7.2.3 North America Animal Blood Plasma Products and Derivatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Animal Blood Plasma Products and Derivatives Sales by Country
- 8.1.1 Europe Animal Blood Plasma Products and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
- 8.1.3 Europe Animal Blood Plasma Products and Derivatives Sales Forecast by Country (2027-2032)
- 8.2 Europe Animal Blood Plasma Products and Derivatives Market Size by Country
- 8.2.1 Europe Animal Blood Plasma Products and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Animal Blood Plasma Products and Derivatives Market Size by Country (2021-2026)
- 8.2.3 Europe Animal Blood Plasma Products and Derivatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales by Country
- 9.1.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Market Size by Country
- 9.2.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Animal Blood Plasma Products and Derivatives Sales by Country
- 10.1.1 South America Animal Blood Plasma Products and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
- 10.1.3 South America Animal Blood Plasma Products and Derivatives Sales Forecast by Country (2027-2032)
- 10.2 South America Animal Blood Plasma Products and Derivatives Market Size by Country
- 10.2.1 South America Animal Blood Plasma Products and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Animal Blood Plasma Products and Derivatives Market Size by Country (2021-2026)
- 10.2.3 South America Animal Blood Plasma Products and Derivatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country
- 11.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Country
- 11.2.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Animal Blood Plasma Products and Derivatives Value Chain Analysis
- 12.1.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Animal Blood Plasma Products and Derivatives Production Mode & Process
- 12.2 Animal Blood Plasma Products and Derivatives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Animal Blood Plasma Products and Derivatives Distributors
- 12.2.3 Animal Blood Plasma Products and Derivatives Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst